Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainVTA is a specialized biotechnology company focused on providing advanced viral vector tools and services for neuroscience research. The company offers a comprehensive portfolio of viral vectors, including Adeno-associated virus (AAV), Lentivirus, Retrovirus, and Rabies virus, specifically optimized for neural circuit tracing and gene delivery in the central nervous system. Beyond product sales, BrainVTA provides custom virus construction, packaging, and stereotaxic injection services to support academic and pharmaceutical researchers. Their technology enables high-resolution mapping of brain connectivity and precise manipulation of neuronal activity through optogenetics and chemogenetics. The company is recognized globally for its expertise in retrograde trans-synaptic tracing using modified rabies virus systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on brainVTA.